These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8113675)

  • 1. TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells.
    Morita A; Takahashi T; Stockert E; Nakayama E; Tsuji T; Matsudaira Y; Old LJ; Obata Y
    J Exp Med; 1994 Mar; 179(3):777-84. PubMed ID: 8113675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive selection of gamma delta CTL by TL antigen expressed in the thymus.
    Tsujimura K; Takahashi T; Morita A; Hasegawa-Nishiwaki H; Iwase S; Obata Y
    J Exp Med; 1996 Dec; 184(6):2175-84. PubMed ID: 8976173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epitope detected by cytotoxic T lymphocytes against thymus leukemia (TL) antigen is TAP independent.
    Tsujimura K; Obata Y; Iwase S; Matsudaira Y; Ozeki S; Takahashi T
    Int Immunol; 2000 Sep; 12(9):1217-25. PubMed ID: 10967016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of CD4 T cells for skin graft rejection against thymus leukemia (TL) antigen and multiple epitopes on the TL molecule recognized by CD4 T cells.
    Tsuji K; Obata Y; Takahashi T; Arata J; Nakayama E
    J Immunol; 1997 Jul; 159(1):159-66. PubMed ID: 9200451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo.
    Lee RS; Grusby MJ; Glimcher LH; Winn HJ; Auchincloss H
    J Exp Med; 1994 Mar; 179(3):865-72. PubMed ID: 8113680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
    Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
    J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of TL, H-2, and chimeric H-2/TL genes in transgenic mice: abnormal thymic differentiation and T-cell lymphomas in a TL transgenic strain.
    Hamasima N; Takahashi T; Taguchi O; Nishizuka Y; Stockert E; Old LJ; Obata Y
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7995-9. PubMed ID: 2813374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymus leukemia antigen (TL)-specific cytotoxic T lymphocytes recognize the alpha1/alpha2 domain of TL free from antigenic peptides.
    Tsujimura K; Obata Y; Kondo E; Nishida K; Matsudaira Y; Akatsuka Y; Kuzushima K; Takahashi T
    Int Immunol; 2003 Nov; 15(11):1319-26. PubMed ID: 14565930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymus-leukemia antigen interacts with T cells and self-peptides.
    Sharma P; Joyce S; Chorney KA; Griffith JW; Bonneau RH; Wilson FD; Johnson CA; Flavell RA; Chorney MJ
    J Immunol; 1996 Feb; 156(3):987-96. PubMed ID: 8558026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
    Lobigs M; Müllbacher A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2676-80. PubMed ID: 8464875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8 expression up to the double-positive CD3(low/intermediate) stage of thymic differentiation is sufficient for development of peripheral functional cytotoxic T lymphocytes.
    Zhang XL; Zhao S; Borenstein SH; Liu Y; Jayabalasingham B; Chamberlain JW
    J Exp Med; 2001 Sep; 194(5):685-93. PubMed ID: 11535636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly restricted expression of the thymus leukemia antigens on intestinal epithelial cells.
    Wu M; van Kaer L; Itohara S; Tonegawa S
    J Exp Med; 1991 Jul; 174(1):213-8. PubMed ID: 1711563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea.
    Tsujimura K; Obata Y; Matsudaira Y; Ozeki S; Taguchi O; Nishida K; Okanami Y; Akatsuka Y; Kuzushima K; Takahashi T
    Cancer Sci; 2004 Nov; 95(11):914-9. PubMed ID: 15546510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological consequences of T cell-specific expression of H-2Kb molecules in transgenic mice.
    Simpson SJ; Tomlinson P; Mellor AL
    Int Immunol; 1993 Feb; 5(2):189-98. PubMed ID: 8095799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal thymic development, impaired immune function and gamma delta T cell lymphomas in a TL transgenic mouse strain.
    Obata Y; Taguchi O; Matsudaira Y; Hasegawa H; Hamasima N; Takahashi T
    J Exp Med; 1991 Aug; 174(2):351-62. PubMed ID: 1713249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
    Dalloul AH; Ngo K; Fung-Leung WP
    Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy.
    Sadovnikova E; Stauss HJ
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13114-8. PubMed ID: 8917553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of high-avidity T cells by thymic epithelium.
    Hoffmann MW; Heath WR; Ruschmeyer D; Miller JF
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9851-5. PubMed ID: 7568231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor-specific antigen.
    Tsujimura K; Obata Y; Takahashi T
    Cancer Sci; 2004 Jun; 95(6):469-74. PubMed ID: 15182425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.